GTR 113945806
Bids Are Invited For Acquisition Of Hospital Medicines
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
113945806
Tendering Authority
Subscribe to view
Tender No
12/2026
Financer Name
Self-Funded
Work Title
Bids Are Invited For Acquisition Of Hospital Medicines
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
11-06-2026
Closed
Work Detail
Alprazolam, 1Mg - Tablet - Br0271356, 2Mg - Tablet - Br0284465, Amoxicillin, Active Ingredient: Associated With Potassium Clavulanate, Concentration: 500Mg + 125Mg, Tablet. - Br0271217, Activated Charcoal, Concentration: 250 Mg, Tablet - Br0434505, Cephalexin, 500Mg. Tablet, - Br0267625, Cinnarizine, Dosage: 75Mg, Tablet. - Br0267629, Citalopram, Dosage: 20 Mg, Tablet - Br0272903, Clonazepam, Dosage: 2Mg, Tablet. - Br0270119, Clonidine Hydrochloride Concentration: 0.1Mg, Tablet. - Br0272043, 2Mg, Tablet. - Br0272042, Clopidogrel, Tablet. - Br0272045, Codeine, Dosage: 30Mg, Tablet. - Br0272782, Diclofenac, Presentation: Sodium Salt, Dosage: 50 Mg, Tablet - Br0271000, Dipyrone Sodium, Dosage: 500 Mg, Tablet - Br0267203, Escitalopram Oxalate, Dosage: 10 Mg, Tablet - Br0291770, Tablet - Br0291771, Scopolamine Butylbromide, Presentation: Associated With Dipyrone Sodium, Dosage: 10Mg + 250Mg, Tablet - Br0270620, Spironolactone, Dosage: 25Mg, Tablet - Br0267653, Flunarizine Dihydrochloride, Dosage: 10Mg - Tablet - Br0272478, Gliclazide, Concentration: 30 Mg, Pharmaceutical Form: Prolonged Release, Tablet - Br0442754, Ibuprofen, Dosage: 600 Mg, Tablet - Br0267676, Imipramine, Active Ingredient: Hydrochloride, Dragee - Br0267293, Principle Active: Hydrochloride, Dosage: 25 Mg, Tablet. - Br0267292, Levomepromazine, Dosage: 100Mg, Tablet - Br0268129, Metformin Hydrochloride, Composition: Associated With Dapaglifozin, Concentration: 1000 Mg + 5 Mg, Pharmaceutical Form: Prolonged Action, Tablet - Br0441621, Methylphenidate Hydrochloride, Dosage: 10Mg - Tablet - Br0272320, Metoprolol, Active Ingredient: Succinate Salt, Dosage: 25 Mg, Presentation: Controlled Release - Tablet - Br0276656., Presentation: Controlled Release - Tablet - Br0276657, Morphine, Presentation; Sulfate, Concentration: 10Mg - Tablet - Br0271392, Nimesulide, Tablet - Br0273710, Omeprazole, Concentration: 20Mg, Tablet - Br0267712, Ondansetron Hydrochloride, Concentration: 4 Mg, Pharmaceutical Form: Orodispersible Tablet - Tablet - Br0419016, Orphenadrine Citrate, Composition: Associated With Dipyrone And Caffeine, Dosage: 35Mg + 300Mg + 50Mg, Tablet. - Br0283156, Oxcarbazepine, Dosage: 300 Mg, Tablet - Br0273257, Paracetamol, Dosage: 750Mg, Tablet - Br0267779, Paroxetine Hydrochloride, Tablet - Br0273940, Pentoxifylline, Dosage: 400 Mg, Tablet - Br0268159, Prednisone, Dosage: 20Mg, Tablet - Br0267743, Risperidone, Dosage: 1Mg, Tablet - Br0272839, Tablet - Br0268149, Sertraline Hydrochloride, Tablet - Br0272364, Dosage: 50Mg, Tablet - Br0272365, Simethicone, Concentration: 40Mg, Tablet - Br0412963, Thioridazine Hydrochloride, Concentration: 25 Mg - Tablet - Br0273597, Tramadol Hydrochloride, Capsule - Br0268534, Trazodone Hydrochloride, Concentration: 150 Mg, Pharmaceutical Form: Release Controlled, Tablet - Br0362260, Venlafaxine, Composition: Hydrochloride Salt, Capsule - Br0470429, B Complex Vitamins, Basic Composition: B1, B2, B3, B5, B6. Tablet - Br0368499., Acebrophylline, Concentration: 10 Mg/Ml, Pharmaceutical Form: Syrup - 120Ml Bottle - Br0448839, Concentration: 5 Mg/Ml, Pharmaceutical Form: Syrup - 120Ml Bottle - Br0448838, Acetylcysteine, Concentration: 600 Mg, Pharmaceutical Form: Granules For Oral Solution - Envelope - Br0434110, Dosage: 20 Mg/Ml, Indication: Syrup - 120Ml Bottle - Br0270558, Concentration: 40 Mg/Ml, Pharmaceutical Form: Syrup, Fr
Key Value
Tender Value
412,175 - BRL
Tender Documents
Global Tender Document
214a9420-c12b-49f9-bb71-016dd1186c22.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.